Showing items 1 - 3 of 3

Your selections:

Lung cancer treatment patterns and factors relating to systemic therapy use in Australia

- Ngo, Preston, Goldsbury, David E., Rankin, Nicole M., Vinod, Shalini, Canfell, Karen, Weber, Marianne F., Karikios, Deme, Yap, Sarsha, Yap, Mei Ling, Egger, Sam, O'Connell, Dianne L., Ball, David, Fong, Kwun M., Pavlakis, Nick

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study

- Shapiro, Jeremy D., Thavaneswaran, Subotheni, Tebbutt, Niall C., Price, Timothy J., Khasraw, Mustafa, Van Hazel, Guy A., Waring, Paul M., Tejpar, Sabine, Simes, John, Gebski, Val J., Desai, Jayesh, Segelov, Eva, Underhill, Craig R., Robledo, Kristy P., Karapetis, Chistos S., Day, Fiona L., Nott, Louise M., Jefford, Michael, Chantrill, Lorraine A., Pavlakis, Nick

Current opinion on optimal treatment for colorectal cancer

- Price, Timothy J., Segelov, Eva, Shapiro, Jeremy D., Burge, Matthew, Haller, Daniel G., Ackland, Stephen P., Tebbutt, Niall C., Karapetis, Christos S., Pavlakis, Nick, Sobrero, Alberto F., Cunningham, David

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit